Cynosure and Lutronic announce merger to form ‘global leader in medical aesthetics technology'

Cynosure and Lutronic, two providers of energy-based medical aesthetic treatment systems and related technologies, have entered into a definitive merger agreement.

The deal hopes to create a global leader in medical aesthetic systems with a diversified, innovative product portfolio and a commercial presence in over 130 countries.

The combined company will provide a broader product and consumables suite, a depth of related clinical training and services, and expanded research and development capabilities.

It will also offer an enhanced geographic footprint to serve more customers around the world and a reinforced supply chain to ensure seamless continuity of products and services.

Nadav Tomer, CEO of Cynosure, said: "The merger will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees."

Haelyung Hwang, Founder and CEO of Lutronic, added: "Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company.

"This strategic combination furthers Lutronic's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world.

"Cynosure's innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally."

The transaction is expected to close in the first quarter of 2024, subject to customary closing condition.